Dr. Marty Makary
๐ค SpeakerAppearances Over Time
Podcast Appearances
They are, but at the same time, they see the demand for this. And if there's demand, they want to make those employees happy because they want to attract employees. Fertility services. Is there an ROI on it? No. But they know there's demand for those fertility services. So that is now enabling... smart people to say, hey, this makes sense medically in terms of improving health. Let's do it.
Let's try it. Let's do a pilot. And it's happening fast. We don't have to wait. These diabetes alternative, these companies now, they're not anti-dialysis. Sorry, I meant dialysis. So in dialysis, we have a system where we just kind of let people go into renal failure, then we put them on the machine. Well, what about actively getting them to avoid dialysis before they become dependent on it?
Let's try it. Let's do a pilot. And it's happening fast. We don't have to wait. These diabetes alternative, these companies now, they're not anti-dialysis. Sorry, I meant dialysis. So in dialysis, we have a system where we just kind of let people go into renal failure, then we put them on the machine. Well, what about actively getting them to avoid dialysis before they become dependent on it?
Let's try it. Let's do a pilot. And it's happening fast. We don't have to wait. These diabetes alternative, these companies now, they're not anti-dialysis. Sorry, I meant dialysis. So in dialysis, we have a system where we just kind of let people go into renal failure, then we put them on the machine. Well, what about actively getting them to avoid dialysis before they become dependent on it?
So there's a couple of companies now, they're not the big ones, and they are actively working with people in that pre-dialysis phase of their life. And if they can avert one patient becoming dependent, it pays for itself. So this is the exciting stuff right now in medicine.
So there's a couple of companies now, they're not the big ones, and they are actively working with people in that pre-dialysis phase of their life. And if they can avert one patient becoming dependent, it pays for itself. So this is the exciting stuff right now in medicine.
So there's a couple of companies now, they're not the big ones, and they are actively working with people in that pre-dialysis phase of their life. And if they can avert one patient becoming dependent, it pays for itself. So this is the exciting stuff right now in medicine.
Oh, it's great to see you, Mark. Keep up the great work. Um, so, um, I felt like there's so much new research that is directly speaking to these blind spots in medicine that people should know about it, not just in the medical community. But if my colleagues are fascinated by some new research that I'm presenting to them in a lecture โ
Oh, it's great to see you, Mark. Keep up the great work. Um, so, um, I felt like there's so much new research that is directly speaking to these blind spots in medicine that people should know about it, not just in the medical community. But if my colleagues are fascinated by some new research that I'm presenting to them in a lecture โ
Oh, it's great to see you, Mark. Keep up the great work. Um, so, um, I felt like there's so much new research that is directly speaking to these blind spots in medicine that people should know about it, not just in the medical community. But if my colleagues are fascinated by some new research that I'm presenting to them in a lecture โ
Some of that research has direct implications for everyday folks out there. And so that's why I put this book together. So I hope people enjoy it.
Some of that research has direct implications for everyday folks out there. And so that's why I put this book together. So I hope people enjoy it.
Some of that research has direct implications for everyday folks out there. And so that's why I put this book together. So I hope people enjoy it.
I'm on Twitter. It's a bit of a nasty place, but I try to encourage people on it and LinkedIn a little bit. But great to be with you. So thanks so much, Mark.
I'm on Twitter. It's a bit of a nasty place, but I try to encourage people on it and LinkedIn a little bit. But great to be with you. So thanks so much, Mark.
I'm on Twitter. It's a bit of a nasty place, but I try to encourage people on it and LinkedIn a little bit. But great to be with you. So thanks so much, Mark.
Raise your hand if you think it should be a civil offense rather than a crime across the border without documentation.
Raise your hand if you think it should be a civil offense rather than a crime across the border without documentation.
Raise your hand if you think it should be a civil offense rather than a crime across the border without documentation.
Well, groupthink is a powerful force. And in medicine, we get sort of medical dogma that takes on a life of its own, and it permeates. And what we develop are these giant blind spots, these areas of medicine and health that affect every aspect of everything we're doing, of every person's health, but we never talk about them.